Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2017 Volume 14 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Low copy number of FCGR3B is associated with lupus nephritis in a Chinese population

  • Authors:
    • Zhaohui Zheng
    • Ruohan Yu
    • Congcong Gao
    • Xianan Jian
    • Songxia Quan
    • Guolan Xing
    • Shengyun Liu
    • Zhangsuo Liu
  • View Affiliations / Copyright

    Affiliations: Department of Rheumatology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China, Department of Nephrology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, P.R. China
  • Pages: 4497-4502
    |
    Published online on: August 30, 2017
       https://doi.org/10.3892/etm.2017.5069
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Lupus nephritis (LN) is a polygenic disease caused by an interaction between hereditary and environmental factors. Numerous gene copy number variations have been identified to contribute to this disease. Previously, immunoglobulin (Ig)G Fcγ receptor 3B (FCGR3B) copy number variation (CNV) was reported to be associated with LN in the Caucasian population. However, the effect of FCGR3B CNV on LN in the Chinese population remains unknown. The present study aimed to investigate whether CNVs of FCGR3B are associated with LN in the Henan Chinese population. FCGR3B CNVs were determined in 142 LN patients and 328 healthy controls. A modified methodology based on competitive polymerase chain reaction, a Multiplex AccuCopy™ kit was used to detect FCGR3B copy number. Clinical and laboratory data was collected retrospectively from medical records. To evaluate associations between FCGR3B CNVs and LN susceptibility, the present study calculated the odds ratios using a logistic regression analysis. The current study identified that the distribution of FCGR3B copy number was significantly different between LN and healthy controls (P=0.031). A low copy number (<2) of FCGR3B was significantly enriched in LN patients (P=0.042), and was a risk factor for LN (odds ratio=2.059; 95% confidence interval, 1.081‑3.921; P=0.028). However, a high copy number (>2) had no effect on LN. There were no associations between FCGR3B CNV and clinical phenotypes of LN. The results from the present study demonstrate that a low copy number of FCGR3B is a risk factor for LN in a Chinese population.
View Figures

Figure 1

Figure 2

View References

1 

Yu C, Gershwin ME and Chang C: Diagnostic criteria for systemic lupus erythematosus: A critical review. J Autoimmun. 48–49:10–13. 2014. View Article : Google Scholar

2 

Choi J, Kim ST and Craft J: The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol. 24:651–657. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, Fiegler H, Shapero MH, Carson AR, Chen W, et al: Global variation in copy number in the human genome. Nature. 444:444–454. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Pacheco GV, Cruz DC, Herrera González LJ, Mendoza Pérez GJ, Amaro Adrián GI, Ueji Nakazawa YE and Ramirez Angulo AV: Copy number variation of TLR-7 gene and its association with the development of systemic lupus erythematosus in female patients from Yucatan Mexico. Genet Epigenet. 6:31–36. 2014.PubMed/NCBI

5 

Kim JH, Jung SH, Bae JS, Lee HS, Yim SH, Park SY, Bang SY, Hu HJ, Shin HD, Bae SC and Chung YJ: Deletion variants of RABGAP1L, 10q21.3, and C4 are associated with the risk of systemic lupus erythematosus in Korean women. Arthritis Rheum. 65:1055–1063. 2013. View Article : Google Scholar : PubMed/NCBI

6 

Garcia-Ortiz H, Velázquez-Cruz R, Espinosa-Rosales F, Jiménez-Morales S, Baca V and Orozco L: Association of TLR7 copy number variation with susceptibility to childhood-onset systemic lupus erythematosus in Mexican population. Ann Rheum Dis. 69:1861–1865. 2010. View Article : Google Scholar : PubMed/NCBI

7 

McKinney C, Merriman ME, Chapman PT, Gow PJ, Harrison AA, Highton J, Jones PB, McLean L, O'Donnell JL, Pokorny V, et al: Evidence for an influence of chemokine ligand 3-like 1 (CCL3L1) gene copy number on susceptibility to rheumatoid arthritis. Ann Rheum Dis. 67:409–413. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Chen JY, Wang CM, Chang SW, Cheng CH, Wu YJ, Lin JC, Yang B, Ho HH and Wu J: Association of FCGR3A and FCGR3B copy number variations with systemic lupus erythematosus and rheumatoid arthritis in Taiwanese patients. Arthritis Rheumatol. 66:3113–3121. 2014. View Article : Google Scholar : PubMed/NCBI

9 

Colombo FR, Torrente Y, Casati R, Benti R, Corti S, Salani S, D'Angelo MG, DeLiso A, Scarlato G, Bresolin N and Gerundini P: Biodistribution studies of 99mTc-labeled myoblasts in a murine model of muscular dystrophy. Nucl Med Biol. 28:935–940. 2001. View Article : Google Scholar : PubMed/NCBI

10 

Nimmerjahn F and Ravetch JV: Fcgamma receptors: Old friends and new family members. Immunity. 24:19–28. 2006. View Article : Google Scholar : PubMed/NCBI

11 

Willcocks LC, Lyons PA, Clatworthy MR, Robinson JI, Yang W, Newland SA, Plagnol V, McGovern NN, Condliffe AM, Chilvers ER, et al: Copy number of FCGR3B, which is associated with systemic lupus erythematosus, correlates with protein expression and immune complex uptake. J Exp Med. 205:1573–1582. 2008. View Article : Google Scholar : PubMed/NCBI

12 

Fanciulli M, Norsworthy PJ, Petretto E, Dong R, Harper L, Kamesh L, Heward JM, Gough SC, de Smith A, Blakemore AI, et al: FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity. Nat Genet. 39:721–723. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Morris DL, Roberts AL, Witherden AS, Tarzi R, Barros P, Whittaker JC, Cook TH, Aitman TJ and Vyse TJ: Evidence for both copy number and allelic (NA1/NA2) risk at the FCGR3B locus in systemic lupus erythematosus. Eur J Hum Genet. 18:1027–1031. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Molokhia M, Fanciulli M, Petretto E, Patrick AL, McKeigue P, Roberts AL, Vyse TJ and Aitman TJ: FCGR3B copy number variation is associated with systemic lupus erythematosus risk in Afro-Caribbeans. Rheumatology (Oxford). 50:1206–1210. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Nossent JC, Becker-Merok A, Rischmueller M and Lester S: Susceptibility for lupus nephritis by low copy number of the FCGR3B gene is linked to increased levels of pathogenic autoantibodies. Autoimmune Dis. 2013:7508142013.PubMed/NCBI

16 

Nossent JC, Rischmueller M and Lester S: Low copy number of the Fc-γ receptor 3B gene FCGR3B is a risk factor for primary Sjogren's syndrome. J Rheumatol. 39:2142–2147. 2012. View Article : Google Scholar : PubMed/NCBI

17 

McKinney C, Broen JC, Vonk MC, Beretta L, Hesselstrand R, Hunzelmann N, Riemekasten G, Scorza R, Simeon CP, Fonollosa V, et al: Evidence that deletion at FCGR3B is a risk factor for systemic sclerosis. Genes Immun. 13:458–460. 2012. View Article : Google Scholar : PubMed/NCBI

18 

Bertsias GK, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, Boletis J, Cervera R, Dörner T, Doria A, et al: Joint European league against rheumatism and European renal Association-European dialysis and transplant association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis. 71:1771–1782. 2012. View Article : Google Scholar : PubMed/NCBI

19 

Hochberg MC: Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 40:17251997. View Article : Google Scholar : PubMed/NCBI

20 

Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N and Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 25:1271–1277. 1982. View Article : Google Scholar : PubMed/NCBI

21 

Dooley MA, Aranow C and Ginzler EM: Review of ACR renal criteria in systemic lupus erythematosus. Lupus. 13:857–860. 2004. View Article : Google Scholar : PubMed/NCBI

22 

Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, et al: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 65:521–530. 2004. View Article : Google Scholar : PubMed/NCBI

23 

Austin HA III, Muenz LR, Joyce KM, Antonovych TT and Balow JE: Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int. 25:689–695. 1984. View Article : Google Scholar : PubMed/NCBI

24 

Gladman DD, Ibañez D and Urowitz MB: Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 29:288–291. 2002.PubMed/NCBI

25 

Du R, Lu C, Jiang Z, Li S, Ma R, An H, Xu M, An Y, Xia Y, Jin L, et al: Efficient typing of copy number variations in a segmental duplication-mediated rearrangement hotspot using multiplex competitive amplification. J Hum Genet. 57:545–551. 2012. View Article : Google Scholar : PubMed/NCBI

26 

Ravetch JV and Perussia B: Alternative membrane forms of Fc gamma RIII(CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J Exp Med. 170:481–497. 1989. View Article : Google Scholar : PubMed/NCBI

27 

Robinson JI, Carr IM, Cooper DL, Rashid LH, Martin SG, Emery P, Isaacs JD, Barton A BRAGGSS, Wilson AG, et al: Confirmation of association of FCGR3B but not FCGR3A copy number with susceptibility to autoantibody positive rheumatoid arthritis. Hum Mutat. 33:741–749. 2012. View Article : Google Scholar : PubMed/NCBI

28 

Niederer HA, Willcocks LC, Rayner TF, Yang W, Lau YL, Williams TN, Scott JA, Urban BC, Peshu N, Dunstan SJ, et al: Copy number, linkage disequilibrium and disease association in the FCGR locus. Hum Mol Genet. 19:3282–3294. 2010. View Article : Google Scholar : PubMed/NCBI

29 

Hollox EJ, Detering JC and Dehnugara T: An integrated approach for measuring copy number variation at the FCGR3 (CD16) locus. Hum Mutat. 30:477–484. 2009. View Article : Google Scholar : PubMed/NCBI

30 

Yuan J, Zhao D, Wu L, Xu X, Pang Y, Zhang J, Ma Y, Liu J and Wang J: FCGR3B copy number loss rather than gain is a risk factor for systemic lupus erythematous and lupus nephritis: A meta-analysis. Int J Rheum Dis. 18:392–397. 2015. View Article : Google Scholar : PubMed/NCBI

31 

Lv J, Yang Y, Zhou X, Yu L, Li R, Hou P and Zhang H: FCGR3B copy number variation is not associated with lupus nephritis in a Chinese population. Lupus. 19:158–161. 2010. View Article : Google Scholar : PubMed/NCBI

32 

Yang H, Zhou Q, Chen D, Jiang H, Mao Y and Chen J: The single nucleotide polymorphisms gene but not the copy number variation of Fcgr3B is associated with lupus nephritis in Chinese people. Lupus. 19:662–664. 2010. View Article : Google Scholar : PubMed/NCBI

33 

Shayakul C, Ong-aj-yooth L, Chirawong P, Nimmannit S, Parichatikanond P, Laohapand T, Vasuvattakul S, Vareesangthip K, Vanichakarn S, Malasit P, et al: Lupus nephritis in Thailand: Clinicopathologic findings and outcome in 569 patients. Am J Kidney Dis. 26:300–307. 1995. View Article : Google Scholar : PubMed/NCBI

34 

Sisó A, Ramos-Casals M, Bové A, Brito-Zerón P, Soria N, Nardi N, Testi A, Perez-de-Lis M, Díaz-Lagares C, Darnell A, et al: Outcomes in biopsy-proven lupus nephritis: Evaluation of 190 white patients from a single center. Medicine (Baltimore). 89:300–307. 2010. View Article : Google Scholar : PubMed/NCBI

35 

Mamtani M, Rovin B, Brey R, Camargo JF, Kulkarni H, Herrera M, Correa P, Holliday S, Anaya JM and Ahuja SK: CCL3L1 gene-containing segmental duplications and polymorphisms in CCR5 affect risk of systemic lupus erythaematosus. Ann Rheum Dis. 67:1076–1083. 2008. View Article : Google Scholar : PubMed/NCBI

36 

Kyogoku C, Dijstelbloem HM, Tsuchiya N, Hatta Y, Kato H, Yamaguchi A, Fukazawa T, Jansen MD, Hashimoto H, van de Winkel JG, et al: Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: Contribution of FCGR2B to genetic susceptibility. Arthritis Rheum. 46:1242–1254. 2002. View Article : Google Scholar : PubMed/NCBI

37 

Li X, Wu J, Carter RH, Edberg JC, Su K, Cooper GS and Kimberly RP: A novel polymorphism in the Fcgamma receptor IIB (CD32B) transmembrane region alters receptor signaling. Arthritis Rheum. 48:3242–3252. 2003. View Article : Google Scholar : PubMed/NCBI

38 

Cai G, Xia Q, Fan D, Li X, Ding N, Hu Y, Yang X, Liu L, Xin L, Wang L, et al: Association between DEFB103 gene copy number variation and ankylosing spondylitis: A case-control study. Tissue Antigens. 86:195–198. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zheng Z, Yu R, Gao C, Jian X, Quan S, Xing G, Liu S and Liu Z: Low copy number of FCGR3B is associated with lupus nephritis in a Chinese population. Exp Ther Med 14: 4497-4502, 2017.
APA
Zheng, Z., Yu, R., Gao, C., Jian, X., Quan, S., Xing, G. ... Liu, Z. (2017). Low copy number of FCGR3B is associated with lupus nephritis in a Chinese population. Experimental and Therapeutic Medicine, 14, 4497-4502. https://doi.org/10.3892/etm.2017.5069
MLA
Zheng, Z., Yu, R., Gao, C., Jian, X., Quan, S., Xing, G., Liu, S., Liu, Z."Low copy number of FCGR3B is associated with lupus nephritis in a Chinese population". Experimental and Therapeutic Medicine 14.5 (2017): 4497-4502.
Chicago
Zheng, Z., Yu, R., Gao, C., Jian, X., Quan, S., Xing, G., Liu, S., Liu, Z."Low copy number of FCGR3B is associated with lupus nephritis in a Chinese population". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4497-4502. https://doi.org/10.3892/etm.2017.5069
Copy and paste a formatted citation
x
Spandidos Publications style
Zheng Z, Yu R, Gao C, Jian X, Quan S, Xing G, Liu S and Liu Z: Low copy number of FCGR3B is associated with lupus nephritis in a Chinese population. Exp Ther Med 14: 4497-4502, 2017.
APA
Zheng, Z., Yu, R., Gao, C., Jian, X., Quan, S., Xing, G. ... Liu, Z. (2017). Low copy number of FCGR3B is associated with lupus nephritis in a Chinese population. Experimental and Therapeutic Medicine, 14, 4497-4502. https://doi.org/10.3892/etm.2017.5069
MLA
Zheng, Z., Yu, R., Gao, C., Jian, X., Quan, S., Xing, G., Liu, S., Liu, Z."Low copy number of FCGR3B is associated with lupus nephritis in a Chinese population". Experimental and Therapeutic Medicine 14.5 (2017): 4497-4502.
Chicago
Zheng, Z., Yu, R., Gao, C., Jian, X., Quan, S., Xing, G., Liu, S., Liu, Z."Low copy number of FCGR3B is associated with lupus nephritis in a Chinese population". Experimental and Therapeutic Medicine 14, no. 5 (2017): 4497-4502. https://doi.org/10.3892/etm.2017.5069
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team